You are here: All Products  > Alphamab Approved to Start US Trials of PD-L1/CTLA-4 Bispecific

Alphamab Approved to Start US Trials of PD-L1/CTLA-4 Bispecific

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products